Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,350 | 4,652 | 4,774 | 5,896 | 5,180 |
| Operating Income | -4,350 | -4,652 | -4,774 | -5,896 | -5,180 |
| Other Income | 172 | 321 | 237 | 21 | 674 |
| Pre-tax Income | -4,177 | -4,331 | -4,537 | -5,875 | -4,506 |
| Net Income Continuous | -4,177 | -4,331 | -4,537 | -5,875 | -4,506 |
| Net Income | $-4,177 | $-4,331 | $-4,537 | $-5,875 | $-4,506 |
| EPS Basic Total Ops | -0.39 | -0.40 | -0.42 | -0.54 | -0.42 |
| EPS Basic Continuous Ops | -0.39 | -0.40 | -0.42 | -0.54 | -0.42 |
| EPS Diluted Total Ops | -0.39 | -0.40 | -0.42 | -0.54 | -0.42 |
| EPS Diluted Continuous Ops | -0.39 | -0.40 | -0.42 | -0.54 | -0.42 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.40 | -0.42 | -0.54 | -0.42 |
| EBITDA(a) | $-4,384 | $-4,709 | $-4,841 | $-5,951 | $-5,262 |